News Archive

2020

March

Media Release / Mar 18, 2020

Novartis Pharmaceuticals Corporation corrective action for certain blister packages of SANDIMMUNE® and NEORAL® 100-mg soft gelatin capsules in the US due to failure to meet child-resistant packaging requirements

Read More
Featured News / Mar 11, 2020

Novartis provides update on use and safety of Beovu® in patients with wet AMD

Read More

February

Scientists are working to develop drugs for individuals living with sickle cell disease
Story / Feb 24, 2020

Shaping the future of sickle cell disease

Collaborations are driving advances in sickle cell disease research, bringing new hope to patients.

Read More
Featured News / Feb 12, 2020

Novartis launches new Preferred Firm Program for legal services

Read More
Media Release / Feb 11, 2020

Novartis announces MET inhibitor capmatinib (INC280), the first potential treatment for METex14 mutated advanced non-small cell lung cancer, granted priority FDA review

Read More

January

Media Release / Jan 16, 2020

Public-Private Collaboration Commits to Accelerate Access to Health Services in Africa, Reaching 1.7 Million People

Read More
Phil Gotwals and colleagues discuss advanced therapy platforms.
Story / Jan 09, 2020

Sourcing innovation, strategically

Phil Gotwals talks about his vision for the future of business development for research.

Read More
2019

December

Media Release / Dec 11, 2019

Novartis announces FDA filing acceptance of Xolair® (omalizumab) for treatment of nasal polyps

Read More
Media Release / Dec 09, 2019

Novartis Kymriah® demonstrates consistent efficacy and safety outcomes in US patients when used in real-world setting

Read More

November

Media Release / Nov 17, 2019

Novartis PARAGON-HF analyses suggest Entresto® benefit beyond HFrEF

Read More

Related Links